Condition: Paroxysmal Nocturnal Hemoglobinuria · Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
This was a phase 1b/2,open label, multi-center study to assess efficacy and safety of HS-10542 in adulte patients with paroxysmal nocturnal hemoglobinuria (PNH) with signs of active hemolysis.
This description comes directly from the study's public registry record.
Yan Hong Tong · 13958122357 · hongyantong@aliyun.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital，Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07470762